London, UK, Sept. 4, 2023 — The Citeline Pharma Intelligence Awards Japan are returning to Tokyo for another year. After a highly successful inaugural event, we are pleased to announce the finalists for 2023. The winners will be revealed at the prestigious Awards on Tuesday, 17 October, at the Palace Hotel in central Tokyo. The awards recognize outstanding advancements and innovations in the Japanese pharma and biotech sector, highlighting Japan’s integral role in the global life sciences and healthcare market.
The shortlist for this year’s Citeline Pharma Intelligence Awards Japan is available to view here: www.citeline.com/awards/citelinepharmaintelligenceawards
The 2023 categories cover the entire pharma and biotech lifecycle. Categories include Best New Drug, Biotech Company of the Year, Best CRO/CDMO, as well as a brand new award for this year, Financing Deal of the Year.
“We are thrilled that the Citeline Pharma Intelligence Awards Japan is returning to Tokyo after the success of last year. We extend our congratulations to all those who are on the finalist list for this year’s Awards – it is a very strong field and we would like to thank those who made some truly incredible entries. We look forward to celebrating the success of the pharma, biotech and global life sciences industries in Tokyo next month,” said Ian Haydock, Editor-In-Chief, APAC.
For further details on the Awards, including booking your table, please visit our website.
Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.
Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline.